Bacitracin and Thrombophlebitis - a phase IV clinical study of FDA data

Summary:

Thrombophlebitis is reported as a side effect among people who take Bacitracin (bacitracin), especially for people who are male, 50-59 old, also take Aredia, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Thrombophlebitis when taking Bacitracin. It is created by eHealthMe based on reports of 1,207 people who have side effects when taking Bacitracin from the FDA, and is updated regularly.

What is Bacitracin?

Bacitracin has active ingredients of bacitracin. eHealthMe is studying from 1,214 Bacitracin users. Check the latest studies of Bacitracin.

What is Thrombophlebitis?

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot) is found to be associated with 939 drugs and 1,267 conditions by eHealthMe. Check the latest studies of Thrombophlebitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,207 people reported to have side effects when taking Bacitracin.
Among them, 16 people (1.33%) have Thrombophlebitis.

Could Bacitracin cause Thrombophlebitis?

Among these 16 people:

What is the gender of people who have Thrombophlebitis when taking Bacitracin? *

female: 18.75 %
male: 81.25 %

What is the age of people who have Thrombophlebitis when taking Bacitracin? *

What are other drugs people take besides Bacitracin? *

What are other side effects people have besides Thrombophlebitis? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 100.00%
Osteonecrosis Of Jaw (death of bone of jaw): 16 people, 100.00%
Pain: 16 people, 100.00%
Fainting (loss of consciousness and postural tone): 16 people, 100.00%
Pain In Jaw: 16 people, 100.00%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 16 people, 100.00%
Infection: 16 people, 100.00%
Pneumonia: 16 people, 100.00%
Emotional Distress: 16 people, 100.00%
Dyspnea (difficult or laboured breathing): 16 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 81.25%
Diabetes: 3 people, 18.75%
Breast Cancer: 3 people, 18.75%
Pyogenic Liver Abscess (liver abscess caused by bacteria): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Bacitracin and have Thrombophlebitis?

- Check whether Thrombophlebitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bacitracin:

Bacitracin (1,214 reports)

Thrombophlebitis treatments and more:

Thrombophlebitis (13,501 reports)

Browse all side effects of Bacitracin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombophlebitis:

Thrombophlebitis (939 drugs)

Browse all the conditions that are associated with Thrombophlebitis:

Thrombophlebitis (1,267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bacitracin (the active ingredients of Bacitracin) and Bacitracin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.